Is MBX Biosciences, Inc. Common Stock (MBX) a Buy, Sell, or Hold?
NASDAQ : MBX
MBX Biosciences, Inc. Common Stock — Analyst Ratings
$63.96 USD
$3.9 (6.49%)
- Volume
- 510.11K
- Average Volume
- 852.79K
- Market Capitalization
- $3.04B
- P/E Ratio
- -29.07
- Dividend Yield
- 0.00%
- Price Target
- $70.00
- Year High
- $66.66
- Year Low
- $9.63
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $30.79
Analyst Consensus Summary
Consensus Rating
Sell
7 Analysts
Rating Score
2/5
Recommendation Strength
Upside/Downside
-8.6%
vs Current Price
Price Target
$70.00
Average TargetPrice Target Range
Lowest Target
$56.00
14.2% UPSIDE
Average Target
$70.00
Median Estimate
Highest Target
$90.00
-28.9% DOWNSIDEAnalyst Breakdown
Overall Consensus: Buy | Total Analysts: 7
| Strong Buy | Buy | Hold | Sell | Strong Sell |
|---|---|---|---|---|
| 0 | 7 | 0 | 0 | 0 |
Analyst Ratings (Detailed)
| Analyst Company | Analyst Name | Price Target | Price When Posted | Date | Upside/Downside |
|---|---|---|---|---|---|
| UBS | Michael Yee | $90 | $61.84 | 2026-07-23 09:37 AM | 45.5% |
| Truist Financial | Srikripa Devarakonda | $70 | $43.79 | 2026-05-11 09:51 AM | 59.9% |
| Truist Financial | Srikripa Devarakonda | $50 | $28.78 | 2026-03-09 08:57 AM | 73.7% |
| Guggenheim | Seamus Fernandez | $88 | $40.91 | 2026-01-16 06:33 AM | 115.1% |
| UBS | Michael Yee | $60 | $28.7 | 2026-01-07 12:44 AM | 109.1% |
| Stifel Nicolaus | Annabel Samimy | $50 | $28.67 | 2025-12-19 07:48 AM | 74.4% |